Neuraxis ups ATM offering to $11.5M after selling 1.125M shares under prior $6.27M program

Neuraxis, INC

On Apr 21, 2026, Neuraxis filed a prospectus supplement increasing the ATM offering cap to $11,500,000 from $6,270,000.
Between Aug 29, 2025 and Apr 20, 2026, the company sold 1,125,281 common shares under the original ATM agreement.
Sales continue through agent Craig-Hallum Capital Group under the existing effective S-3 registration statement (No. 333-283798).
Proceeds from any future sales will be used for general corporate purposes as determined by management.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.